Campus Units

Genetics, Development and Cell Biology

Document Type

Article

Publication Version

Published Version

Publication Date

2013

Journal or Book Title

Genome Medicine

Volume

5

First Page

35

DOI

10.1186/gm439

Abstract

Personalized genomics will only be useful for monitoring the prognosis of patients with cancer when it becomes much more cost-effective and quicker to apply. A recent study brings this closer to reality with the development of plasma-seq, a rapid, low-cost method that sequences the circulating DNA present in the peripheral blood of patients with cancer. The power of this technique is demonstrated with the examination of tumor genomes from patients with prostate cancer.

Comments

This article is from Genome Medicine 5 (2013): 35, doi: 10.1186/gm439. Posted with permission.

Rights

This article is made available under a CC-BY license 4.0. For more information, please visit: https://creativecommons.org/licenses/by/4.0/

Copyright Owner

BioMed Central Ltd

Language

en

File Format

application/pdf

Share

COinS